- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Incorporated in 1981, Emcure Pharmaceuticals Limited is an Indian company that develops, manufactures, and markets a wide range of pharmaceutical products globally across several major therapeutic areas.
Emcure Pharmaceuticals announced its 45th Annual General Meeting (AGM) via video conference. The Annual Report for FY 2025-26 is available online. Shareholders with physical shares need to update KYC; also, submit documents for TDS exemption on the final dividend.
CARE Ratings Limited has reaffirmed Emcure Pharma's Long-term and Short-term bank facilities at CARE AA; Stable / CARE A1+. The stable outlook reflects the company's healthy business profile, diversified revenue of ₹9,322 Cr in FY26 (+18% YoY), and improved profitability with a 20% PBILDT margin. Strong capital structure and strategic...